Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comprehensive clinical rule to diagnose acute heart failure in the emergency department

Official title: Establishing a Comprehensive Clinical Prediction Rule for the Diagnosis of Acute Heart Failure in the Emergency Department

Run by Chinese University of Hong Kong · NCT07754084 · Data updated 2026-11-12

A prospective study tests a combined clinical rule using patient data, a point-of-care NT-proBNP test, an 8-point lung ultrasound, and bedside echo to quickly diagnose acute heart failure in adults with new or worsening symptoms.

More Acute Heart Failure (AHF) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment560 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations3 sites (Hong Kong and 2 other locations)
StatusRecruiting
StartedAugust 17, 2026
Main results expectedDecember 31, 2028
Study endsJanuary 31, 2029
Registry record updatedNovember 5, 2026
Trial IDNCT07754084 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with suspected acute heart failure or acute dyspnea.

Probably not a fit

Patients without acute heart failure or those not fitting the diagnostic pathway may not benefit from the rule.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study aims to develop a comprehensive prediction rule for diagnosing acute heart failure in the emergency department. It combines traditional clinical characteristics with point-of-care NT-proBNP testing, an 8-point lung ultrasound score, and rapid bedside echocardiography. The primary outcome is a validated diagnosis of acute heart failure, with secondary outcomes including ED and discharge diagnoses. The goal is to reduce diagnostic delays and improve accuracy to minimize potential harm to patients. The study is led by The Chinese University of Hong Kong with several collaborating hospitals in Hong Kong.

Why it matters

Potential benefit: If successful, the rule could speed up accurate diagnosis and reduce unnecessary treatments for patients with suspected acute heart failure.

How similar studies have gone: Previous research has shown that combining clinical data with imaging and biomarker information can improve heart failure diagnosis, but this exact integrated rule is being tested in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult (aged ≥ 18 years)
* Suspected AHF or acute dyspnea
* Symptoms include shortness of breath, swelling of legs, orthopnea, paroxysmal nocturnal dyspnoea, exertional dyspnea or weight gain

Exclusion Criteria:

* Trauma patients
* Pregnancy
* Unstable patients requiring invasive airway intervention
* Patients who refuse to participate

Where it's running

  • Prince of Wales Hospital
    Hong Kong, Hong Kong
    Recruiting
  • Queen Mary Hospital
    Hong Kong, Hong Kong
    Not yet recruiting
  • Tuen Mun Hospital
    Hong Kong, Hong Kong
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.